Optimizing expression of Nanobody ® molecules in Pichia pastoris through co-expression of auxiliary proteins under methanol and methanol-free conditions
Ablynx NV, a subsidiary of Sanofi, has a long-standing focus on the development of Nanobody ® molecules as biopharmaceuticals (Nanobody® is a registered trademark of Ablynx NV). Nanobody molecules are single va...
Source: Microbial Cell Factories - Category: Microbiology Authors: Manu De Groeve, Bram Laukens and Peter Schotte Tags: Research Source Type: research
More News: Microbiology | Nanotechnology